Determination of optimal regularization factor in Bayesian penalized likelihood reconstruction of brain PET images using [18F]FDG and [11C]PiB

被引:13
|
作者
Wagatsuma, Kei [1 ,2 ]
Miwa, Kenta [3 ]
Kamitaka, Yuto [2 ]
Koike, Emiya [4 ]
Yamao, Tensho [3 ]
Yoshii, Tokiya [4 ]
Kobayashi, Rinya [5 ]
Nezu, Shogo [6 ]
Sugamata, Yuta [6 ]
Miyaji, Noriaki [7 ]
Imabayashi, Etsuko [8 ]
Ishibashi, Kenji [2 ]
Toyohara, Jun [2 ]
Ishii, Kenji [2 ]
机构
[1] Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, 1-15-1 Kitazato, Sagamihara, Kanagawa 2520373, Japan
[2] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Itabashi Ku, Sakae Cho, Tokyo, Japan
[3] Fukushima Med Univ, Sch Hlth Sci, Dept Radiol Sci, Sakaemachi, Fukushima, Japan
[4] Fukushima Med Univ Hosp, Dept Radiol, Hikarigaoka, Fukushima, Japan
[5] Tokai Univ Hosp, Dept Radiol, Isehara, Kanagawa, Japan
[6] Int Univ Hlth & Welf, Sch Hlth Sci, Dept Radiol Sci, Ohtawara, Tochigi, Japan
[7] Japanese Fdn Canc Res, Dept Nucl Med, Canc Inst Hosp, Koto Ku, Tokyo, Japan
[8] Natl Inst Quantum Sci & Technol, Inst Quantum Med Sci, Dept Mol Imaging & Theranost, Quantum Life & Med Sci Directorate,Inage Ku, Chiba, Japan
关键词
Alzheimer disease; amyloid PET; Bayesian penalized likelihood; Q; Clear; TIME-OF-FLIGHT; DISEASE; OPTIMIZATION; GUIDELINE; PHANTOM;
D O I
10.1002/mp.15593
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose The Bayesian penalized likelihood (BPL) reconstruction algorithm, Q.Clear, can achieve a higher signal-to-noise ratio on images and more accurate quantitation than ordered subset-expectation maximization (OSEM). The reconstruction parameter (beta) in BPL requires optimization according to the radiopharmaceutical tracer. The present study aimed to define the optimal beta value in BPL required to diagnose Alzheimer disease from brain positron emission tomography (PET) images acquired using F-18-fluoro-2-deoxy-D-glucose ([F-18]FDG) and C-11-labeled Pittsburg compound B ([C-11]PiB). Methods Images generated from Hoffman 3D brain and cylindrical phantoms were acquired using a Discovery PET/computed tomography (CT) 710 and reconstructed using OSEM + time-of-flight (TOF) under clinical conditions and BPL + TOF (beta = 20-1000). Contrast was calculated from images generated by the Hoffman 3D brain phantom, and noise and uniformity were calculated from those generated by the cylindrical phantom. Five cognitively healthy controls and five patients with Alzheimer disease were assessed using [F-18]FDG and [C-11]PiB PET to validate the findings from the phantom study. The beta values were restricted by the findings of the phantom study, then one certified nuclear medicine physician and two certified nuclear medicine technologists visually determined optimal beta values by scoring the quality parameters of image contrast, image noise, cerebellar stability, and overall image quality of PET images from 1 (poor) to 5 (excellent). Results The contrast in BPL satisfied the Japanese Society of Nuclear Medicine (JSNM) criterion of >= 55% and exceeded that of OSEM at ranges of beta = 20-450 and 20-600 for [F-18]FDG and [C-11]PiB, respectively. The image noise in BPL satisfied the JSNM criterion of <= 15% and was below that in OSEM when beta = 150-1000 and 400-1000 for [F-18]FDG and [C-11]PiB, respectively. The phantom study restricted the ranges of beta values to 100-300 and 300-500 for [F-18]FDG and [C-11]PiB, respectively. The BPL scores for gray-white matter contrast and image noise, exceeded those of OSEM in [F-18]FDG and [C-11]PiB images regardless of beta values. Visual evaluation confirmed that the optimal beta values were 200 and 450 for [F-18]FDG and [C-11]PiB, respectively. Conclusions The BPL achieved better image contrast and less image noise than OSEM, while maintaining quantitative standardized uptake value ratios (SUVR) due to full convergence, more rigorous noise control, and edge preservation. The optimal beta values for [F-18]FDG and [C-11]PiB brain PET were apparently 200 and 450, respectively. The present study provides useful information about how to determine optimal beta values in BPL for brain PET imaging.
引用
收藏
页码:2995 / 3005
页数:11
相关论文
共 50 条
  • [1] Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET
    Ossenkoppele, Rik
    Tolboom, Nelleke
    Foster-Dingley, Jessica C.
    Adriaanse, Sofie F.
    Boellaard, Ronald
    Yaqub, Maqsood
    Windhorst, Albert D.
    Barkhof, Frederik
    Lammertsma, Adriaan A.
    Scheltens, Philip
    van der Flier, Wiesje M.
    van Berckel, Bart N. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (06) : 990 - 1000
  • [2] Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET
    Rik Ossenkoppele
    Nelleke Tolboom
    Jessica C. Foster-Dingley
    Sofie F. Adriaanse
    Ronald Boellaard
    Maqsood Yaqub
    Albert D. Windhorst
    Frederik Barkhof
    Adriaan A. Lammertsma
    Philip Scheltens
    Wiesje M. van der Flier
    Bart N. M. van Berckel
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 990 - 1000
  • [3] Optimization of Bayesian penalized likelihood reconstruction algorithm for [18F]flutemetamol amyloid PET images
    Fukuda, S.
    Miwa, K.
    Wagatsuma, K.
    Yakushiji, Y.
    Yamao, T.
    Kamitaka, Y.
    Nishikawa, N.
    Hasegawa, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S607 - S607
  • [4] Investigation of Optimal Reconstruction Conditions Using the Bayesian Penalized-Likelihood Algorithm in [18F]fluciclovine PET Imaging for Brain Tumors
    Tsuzura, K.
    Wagatsuma, K.
    Yokotsuka, N.
    Miwa, K.
    Kamitaka, Y.
    Tanimoto, K.
    Nishii, R.
    Ishii, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S505 - S505
  • [5] Amyloid, hypometabolism, and cognition in Alzheimer disease - An [11C]PIB and [18F]FDG PET study
    Edison, P.
    Archer, H. A.
    Hinz, R.
    Hammers, A.
    Pavese, N.
    Tai, Y. F.
    Hotton, G.
    Cutler, D.
    Fox, N.
    Kennedy, A.
    Rossor, M.
    Brooks, D. J.
    NEUROLOGY, 2007, 68 (07) : 501 - 508
  • [6] Optimization of penalization function in Bayesian penalized likelihood reconstruction algorithm for [18F]flutemetamol amyloid PET images
    Fukuda, Shohei
    Wagatsuma, Kei
    Miwa, Kenta
    Yakushiji, Yu
    Kamitaka, Yuto
    Yamao, Tensho
    Miyaji, Noriaki
    Ishii, Kenji
    PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 2024, 47 (04) : 1627 - 1637
  • [7] Protective role of β-amyloid revealed by PET of [11C]PiB and [18F]FDG in Alzheimer's disease
    Rischel, Elise
    Gejl, Michael
    Brock, Birgitte
    Rungby, Jorgen
    Gjedde, Albert
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (1_SUPPL): : 188 - 189
  • [8] [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment
    Bruck, A.
    Virta, J. R.
    Koivunen, J.
    Koikkalainen, J.
    Scheinin, N. M.
    Helenius, H.
    Nagren, K.
    Helin, S.
    Parkkola, R.
    Viitanen, M.
    Rinne, J. O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (10) : 1567 - 1572
  • [9] [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment
    A. Brück
    J. R. Virta
    J. Koivunen
    J. Koikkalainen
    N. M. Scheinin
    H. Helenius
    K. Någren
    S. Helin
    R. Parkkola
    M. Viitanen
    J. O. Rinne
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 1567 - 1572
  • [10] Longitudinal [11C]PIB and [18F]FDDNP PET studies on memory in patients and controls
    Ossenkoppele, R.
    Tolboom, N.
    van der Flier, W. M.
    Yaqub, M.
    Windhorst, A. D.
    Boellaard, R.
    Barkhof, F.
    Lammertsma, A. A.
    Scheltens, P.
    van Berckel, B. N. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S560 - S561